Log In
BCIQ
Print this Print this
 

SYN-001

  Manage Alerts
Collapse Summary General Information
Company Synactix Pharmaceuticals Inc.
DescriptionDual targeted kinase inhibitor
Molecular Target
Mechanism of ActionKinase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today